Urological cancer, Malmö
311 – 320 of 499
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Midkine is part of the antibacterial activity released at the surface of differentiated bronchial epithelial cells
(
- Contribution to journal › Article
-
Mark
miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer.
(
- Contribution to journal › Article
-
Mark
Low expression of SHP-2 is associated with less favorable prostate cancer outcomes.
(
- Contribution to journal › Article
-
Mark
Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Pituitary disease mortality: is it fiction?
(
- Contribution to journal › Article
-
Mark
Modeling Costs for Prostate Surgery: Are We Close to Reality?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The tumour suppressor miR-34c targets MET in prostate cancer cells.
(
- Contribution to journal › Article
-
Mark
A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.
(
- Contribution to journal › Article
-
Mark
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
(
- Contribution to journal › Article
- 2012
-
Mark
A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens
(
- Contribution to journal › Scientific review